Meredith M. Regan - Concepedia

Author

Meredith M. Regan

Also Known As

Alan S. Coates, Alfredo Berruti, D. Sonetti, David H. Howard, Francesco Perrone, Hervé Bonnefoi, James M. Rae, John T. Wei, Larry Hembroff, M Kaufmann

675

Publications

41.6K

Citations

H-Index

197

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Beth Israel Deaconess Medical Center European Institute of Oncology International Breast Cancer Study Group

About

Meredith M. Regan is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	89	11.4K
2	Health Sciences	17	23	1.6K
3	Engineering	3	3	463
4	Education	2	2	45
5	Management	1	1	33

Meredith M. Regan

246

Publications

33.4K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan, Journal of Clinical Oncology	2009	2.1K
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update Kimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett, Journal of Clinical Oncology	2020	1.4K
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer, Annals of Oncology	2017	1.2K
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial Viviana Galimberti, Bernard F. Cole, Stefano Zurrida, The Lancet Oncology Ibcsg 23–01Surgical PathologySentinel-node MicrometastasesSurgeryAxillary Dissection	2013	1.2K
Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk Hans K. Meier-Ewert, Paul M. Ridker, Nader Rifai, Journal of the American College of Cardiology InflammationMetabolic SyndromeSleepSleep DisorderCardiovascular Disease	2004	1.2K
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan, The Lancet Oncology External ValidationUrologyPopulation-based StudyGenitourinary CancerMedicine	2013	1K
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline Larissa A. Korde, Mark R. Somerfield, Lisa A. Carey, Journal of Clinical Oncology	2021	923
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer Qianben Wang, Wei Li, Yong Zhang, Cell Androgen ReceptorTranscriptional RegulationUrologySystems BiologyHormonal Receptor	2009	898
Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma David F. McDermott, Meredith M. Regan, Joseph I. Clark, Journal of Clinical Oncology	2004	814
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer Olivia Pagani, Meredith M. Regan, Barbara Walley, New England Journal of Medicine	2014	738

Page 1